German custom manufacturing specialist Saltigo GmbH signed in Tokyo an agreement with Daiichi Sankyo Co., Ltd. for the provision of contract manufacturing services. These are associated with the preparation for commercialization of one of Daiichi Sankyo’s novel drug pipeline projects. A corresponding signing ceremony took place in Tokyo. Present were Dr. Katsumi Fujimoto, Executive Vice President, Pharmaceutical Technology Division of Daiichi Sankyo, and Wolfgang Schmitz, Managing Director of Saltigo.
Schmitz comments: “Daiichi Sankyo is one of the largest pharma players in the second largest pharma market in the world and decided to work with a globally recognized CMO-partner such as our company. So, it is a great honor for Saltigo to enter into this agreement with Daiichi Sankyo and we look forward to the continuation and further proactive development of our business relationship.”
Jörg Schneider, Saltigo’s Head of Marketing, adds: “Daiichi Sankyo has a strong reputation for innovation, which is reflected in its excellent new drug pipeline. This agreement highlights our ability to provide our customers worldwide with the highest possible standards in quality and operational performance.”
